Share chart Anebulo Pharmaceuticals, Inc.
Extended chart
Simple chart
About Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. The company was incorporated in 2020 and is based in Lakeway, Texas.Main settings
IPO date
2021-05-07
ISIN
US0345691036
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 0 | 0 |
| P/BV | 18.96 | 1 |
| P/E | 0 | 0 |
Efficiency
| Title | Value | Grade |
| ROA | -104.19 | 0 |
| ROE | -113.8 | 0 |
| ROIC | 0 | 0 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0 | 0 |
| DSI | 0 | 0 |
| Average dividend growth | 0 | 0 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | 0 | 10 |
| Debt/Ratio | 0 | 10 |
| Debt/Equity | 0.0683 | 10 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 0 | 0 |
| Yield Ebitda, % | 123.62 | 10 |
| Yield EPS, % | -75.49 | 0 |
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 1.13 $ | 0 $ | 0 $ | -4.42 % | 0 % | 0 % |
| Week | 1.12 $ | 0 $ | 0 $ | -3.57 % | 0 % | 0 % |
| Month | 1.15 $ | 0.9751 $ | 1.13 $ | -6.09 % | 0 % | 0 % |
| Three month | 1.23 $ | 0.9447 $ | 2.04 $ | -12.2 % | 0 % | 0 % |
| Half a year | 1.43 $ | 0.9447 $ | 2.04 $ | -24.48 % | 0 % | 0 % |
| Year | 2.08 $ | 0.9447 $ | 3.08 $ | -48.08 % | 0 % | 0 % |
| 3 years | 3.06 $ | 0.9447 $ | 5.49 $ | -64.71 % | 0 % | 0 % |
| 5 years | 0 $ | 0.9447 $ | 8.95 $ | 0 % | 0 % | 0 % |
| 10 years | 0 $ | 0.9447 $ | 8.95 $ | 0 % | 0 % | 0 % |
| Year to date | 1.25 $ | 0.9447 $ | 2.04 $ | -13.6 % | 0 % | 0 % |
Main owners
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Dr. Joseph F. Lawler M.D., Ph.D. | Founder & Chairman | 11k | 1972 (53 years) |
| Dr. Kenneth C. Cundy Ph.D. | Chief Scientific Officer | 425.15k | 1959 (66 years) |
| Mr. Richard Anthony Cunningham | CEO & Director | N/A | 1971 (54 years) |
| Mr. Daniel V. George | Principal Accounting Officer, Acting CFO & Secretary | N/A | 1970 (55 years) |
About company
Address: United States, Lakeway. TX, 1017 Ranch Road 620 South - Open in google maps, Open in yandex maps
Website: https://www.anebulo.com
Website: https://www.anebulo.com
